Switzer TV

 

Welcome back for another year of stock picks, top LICs and trading tips with Switzer Investing TV. Good to have you aboard.

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

In this first show of the year, Peter Switzer sits down with Adam Dawes from Shaw and Partners, Mike Gable from Fairmont Equities, and Paul Rickard from the Switzer Report to cut through the noise.

They run the ruler over some of the market’s most talked-about names, including CSL, NextDC, Xero, WiseTech, Pro Medicus, lithium plays, uranium stocks, and gold. Fundamentals meet charts, sentiment clashes with valuation, and the panel doesn’t always agree. You’ll hear why great businesses can fall a long way without anything being “wrong”, what the charts are really saying about beaten-up tech, why resources have momentum again, and whether gold is still a defensive play with upside in 2026.

Switzer Investing TV (19/12/25): Are these smashed stocks worth your time?

On this kick-off ep for the new year, we're looking at roughed-up companies on the market that might be worth a second look. Quality stocks are being sold hard, resources are back in favour, and investors are asking the same uncomfortable question, is this a buying opportunity or a value trap?

More videos

Do dairy products really increase cancer risk? | The Check Up

Recently a medical item came out with the headline, 'Dairy products increase cancer risk'. Dr Ross analyses this study and gives his insight on the topic.

Series:
Has the stock market bottomed? + Rudi & Kelli on the stocks they like right now!

Peter Switzer is joined by Rudi Filapek-Vandyck of FNArena, Kelli Meagher of Sage Capital, and commercial property specialist Helen Tarrant.

Series:
Mad about Money

Peter Switzer and Paul Rickard share their thoughts on the major current affairs impacting financial markets and the economy.

Series:
Is it time to buy tech stocks? + Has the stock market bottomed?

Peter Switzer is joined by Paul Rickard from the Switzer Report, Shane Oliver of AMP Capital, and Chief Economist of Morgans, Michael Knox.

Series:
The best way to combat COVID is to keep your immune system healthy - Here's how! | The Check Up

Dr Ross discusses 5 things the healthiest people on the planet do, which is essential in reducing and helping battle the detrimental effects of COVID on our bodies.

Series:
ST Wong looks at 3 interesting stocks! + Is rising interest rates an opportunity for investors?

Paul Rickard takes a deep dive into infrastructure and how you can invest in the sector and is also joined by ST Wong of Prime Value, and Arjun Paliwal of InvestorKit.

Series:
Mad about Money

Paul Rickard shares his thoughts on the major current affairs impacting financial markets and the economy.

Series:
What stocks could benefit from higher interest rates? + Paul Rickard's winning and losing stocks!

Paul Rickard takes a look at the winners and losers for Monday, and is joined by Raymond Chan of Morgans, and Ron Shamgar of TAMIM Asset Management.

Series:
What is a cytokine storm and how is it connected to COVID19? | The Check Up

Dr Ross explains how a cytokine storm is caused due to COVID19 and looks at a possible monoclonal antibody that can help improve symptoms.

Series:
Michael Gable on whether CBA & FMG are potential buys + should you buy off the plan?

Paul Rickard is joined by Michael Gable of Fairmont Equities, and Angus Moore of PropTrack, while Peter Switzer is joined by property expert Margaret Lomas, and also gives his take on what he's seeing in the market right now.

Series:
Mad about Money

Paul Rickard shares his thoughts on the major current affairs impacting financial markets and the economy.

Series:
What are the lasting symptoms that come with long COVID? | The Check Up

Dr Ross explores the three cardinal symptoms of long Covid - fatigue, brain fog and shortness of breath.

Series:
1 13 14 15 16 17 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram